Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1967;36:692-699

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LIEBERSON, A. D.
Right arrow Articles by WILLIAMS, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LIEBERSON, A. D.
Right arrow Articles by WILLIAMS, J. F., JR.

(Circulation. 1967;36:692.)
© 1967 American Heart Association, Inc.


Effect of Diphenylhydantoin on Left Ventricular Function in Patients with Heart Disease

ALAN D. LIEBERSON M.D.1; RICHARD R. SCHUMACHER M.D.1; RICHARD H. CHILDRESS M.D.1; DANIEL L. BOYD M.D.1; JOHN F. WILLIAMS JR. M.D.1

1 From the Medical Service, Veterans Administration Hospital, and the Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.

The effect of 250 mg of diphenylhydantoin, administered intravenously, on left ventricular function was determined during cardiac catheterization in nine patients with heart disease.

Five minutes after drug administration, left ventricular end-diastolic pressure rose in each patient from an average of 6.0 mm Hg to 10.0 mm Hg. Concurrently, stroke work and stroke power indices decreased in each patient by an average of 22.0% and 22.2%, respectively. Stroke volume index decreased in seven patients and maximum left ventricular dp/dt fell in eight patients. Over the next 25 minutes, all parameters returned to control values. Cardiac index was unchanged, whereas generally small and insignificant changes were observed in heart rate and systemic arterial pressure throughout the study.

Although this study has demonstrated that diphenylhydantoin depresses myocardial function, the effect may have limited clinical significance since it was relatively short-lived and did not reduce cardiac output or greatly elevate ventricular end-diastolic pressure. Furthermore, the absence of a significant systemic hypotensive effect is of distinct clinical importance.


Key Words: Cardiac output • Systemic arterial pressure